Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising results. However, the expense of this innovative drug and its availability have become key concerns for patients and healthcare providers. While tirzepatide has been authorized by regulatory agencies, its costly nature presents a significant challenge to